425 related articles for article (PubMed ID: 17976278)
1. Retail prices of essential drugs in Brazil: an international comparison.
Nóbrega Ode T; Marques AR; de Araújo AC; Karnikowski MG; Naves Jde O; Silver LD
Rev Panam Salud Publica; 2007 Aug; 22(2):118-23. PubMed ID: 17976278
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
3. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.
Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M
Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644
[TBL] [Abstract][Full Text] [Related]
4. Does Pharmaceutical Pricing Transparency Matter? Examining Brazil's Public Procurement System.
Kohler JC; Mitsakakis N; Saadat F; Byng D; Martinez MG
Global Health; 2015 Aug; 11():34. PubMed ID: 26238110
[TBL] [Abstract][Full Text] [Related]
5. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
6. High prices for generics in Australia - more competition might help.
Bulfone L
Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
[TBL] [Abstract][Full Text] [Related]
7. Inflated medicine prices in Vietnam: a qualitative study.
Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
Health Policy Plan; 2017 Jun; 32(5):647-656. PubMed ID: 28453716
[TBL] [Abstract][Full Text] [Related]
8. Price discrimination in essential medicines: evidence from International Drug Price Indicator Guide data.
Hanlon M; Zhang R
Int Health; 2013 Mar; 5(1):58-63. PubMed ID: 24029847
[TBL] [Abstract][Full Text] [Related]
9. Assistive technology pricing in Australia: is it efficient and equitable?
Summers MP; Verikios G
Aust Health Rev; 2018 Feb; 42(1):100-110. PubMed ID: 28160784
[TBL] [Abstract][Full Text] [Related]
10. Expanding drug access in Brazil: lessons for Latin America and Canada.
Cohen JC
Can J Public Health; 2006; 97(6):I15-8. PubMed ID: 17203728
[TBL] [Abstract][Full Text] [Related]
11. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
12. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
Vogler S; Vitry A; Babar ZU
Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
[TBL] [Abstract][Full Text] [Related]
13. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
14. Determinants of drug prices: a systematic review of comparison studies.
Janssen Daalen JM; den Ambtman A; Van Houdenhoven M; van den Bemt BJF
BMJ Open; 2021 Jul; 11(7):e046917. PubMed ID: 34266841
[TBL] [Abstract][Full Text] [Related]
15. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
16. Comparison between maximum consumer prices for medicines and prices practiced on the internet in Brazil: misalignments and regulatory distortions.
Souza CMA; Paranhos J; Hasenclever L
Cien Saude Colet; 2021 Nov; 26(11):5463-5480. PubMed ID: 34852083
[TBL] [Abstract][Full Text] [Related]
17. Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose.
Bergman MA; Granlund D; Rudholm N
Int J Health Econ Manag; 2016 Sep; 16(3):201-214. PubMed ID: 27878673
[TBL] [Abstract][Full Text] [Related]
18. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil.
Nunn A; Fonseca ED; Gruskin S
Glob Public Health; 2009; 4(2):131-49. PubMed ID: 19333805
[TBL] [Abstract][Full Text] [Related]
19. The prices people pay for medicines in Zimbabwe.
Gavaza P; Simoyi T; Makunike B; Maponga CC
Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
[TBL] [Abstract][Full Text] [Related]
20. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
